TrialEuropean journal of heart failure2025

Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI).

Jaclyn Carberry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.